Direct Oral AnticoagulantsDirect oral anticoagulants include two groups of drugs. Factor Xa inhibitors and direct thrombin inhibitors both help to stop clots. Medicine in these categories include:
There are no studies that look at the direct effect of supplements on this class of drugs. However, certain supplements have shown the ability to affect how blood clots. When combined with this medicine they may increase the risk of bleeding. Let your doctor know about any supplements you are taking or plan to start. Possible interactions can occur with: Possible Harmful Interaction Fish oil may increase the risk of bleeding when combined with direct oral anticoagulants. The larger the dose of fish oil, the larger the risk of bleeding. Fish oil includes omega-3 fatty acids and cod liver oil. Talk to your doctor before taking fish oil supplements.1-3 Possible Harmful Interaction St. John’s wort may reduce the amount of some direct oral anticoagulants in the blood. This can lower the effect of the drugs. Avoid St. John’s wort while taking this medicine.1-2, 4 Other herbs and natural supplements might interfere with the ability of the blood to clot. However, it is not clear if it increases the effect of this class of medication. References►1. Rivaroxaban. EBSCO DynaMed Plus website. Available at: http://www.dynamed.com/topics/dmp~AN~T901914/Rivaroxaban. Updated March 6, 2018. Accessed September 7, 2018. 2. Dabigatran. EBSCO DynaMed Plus website. Available at: http://www.dynamed.com/topics/dmp~AN~T901029/Dabigatran#Drug-Interactions. Updated September 6, 2018. Accessed September 7, 2018. 3. Apixaban. EBSCO DynaMed Plus website. Available at: http://www.dynamed.com/topics/dmp~AN~T904822/Apixaban#Drug-Interactions. Updated September 6, 2018. Accessed September 7, 2018. 4. Edoxaban. EBSCO DynaMed Plus website. Available at: http://www.dynamed.com/topics/dmp~AN~T908365/Edoxaban#Drug-Interactions. Updated September 6, 2018. Accessed September 7, 2018. 5. Rivaroxaban—drug summary. PDR—Prescribers’ Digital Reference website. Available at: http://www.pdr.net/drug-summary/Xarelto-rivaroxaban-278#13. Accessed April 11, 2018. Last reviewed September 2018 by EBSCO CAM Review Board Last Updated: 2/21/2019 | |
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation. This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition. To send comments or feedback to our Editorial Team regarding the content please email us at healthlibrarysupport@ebsco.com. Our Health Library Support team will respond to your email request within 2 business days. | |